Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

2.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
3.

Escitalopram: a review of its use in the management of major depressive disorder.

Murdoch D, Keam SJ.

Drugs. 2005;65(16):2379-404. Review.

PMID:
16266205
4.

Escitalopram: a pharmacoeconomic review of its use in depression.

Croom KF, Plosker GL.

Pharmacoeconomics. 2003;21(16):1185-209. Review.

PMID:
14594439
5.

Bupropion: a review of its use in the management of major depressive disorder.

Dhillon S, Yang LP, Curran MP.

Drugs. 2008;68(5):653-89. Review. Erratum in: Drugs. 2008;68(7):980.

PMID:
18370448
6.

Spotlight on the pharmacoeconomics of escitalopram in depression.

Croom KF, Plosker GL.

CNS Drugs. 2004;18(7):469-73. Review.

PMID:
15139801
7.

Managing depressive and anxiety disorders with escitalopram.

Thase ME.

Expert Opin Pharmacother. 2006 Mar;7(4):429-40. Review.

PMID:
16503815
8.
9.

Escitalopram: a review of its use in the management of major depressive disorder in adults.

Garnock-Jones KP, McCormack PL.

CNS Drugs. 2010 Sep;24(9):769-96. doi: 10.2165/11204760-000000000-00000. Review.

PMID:
20806989
10.
11.

[Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

Favré P.

Encephale. 2012 Feb;38(1):86-96. doi: 10.1016/j.encep.2011.11.003. Epub 2011 Dec 10. Review. French.

PMID:
22381728
12.

Spotlight on bupropion in major depressive disorder.

Dhillon S, Yang LP, Curran MP.

CNS Drugs. 2008;22(7):613-7. Review.

PMID:
18547129
13.

The pharmacoeconomics of venlafaxine in depression.

Morrow TJ.

Am J Manag Care. 2001 Sep;7(11 Suppl):S386-92. Review.

14.

Remission from depression : a review of venlafaxine clinical and economic evidence.

Han D, Wang EC.

Pharmacoeconomics. 2005;23(6):567-81. Review.

PMID:
15960553
15.

Escitalopram.

Aronson S, Delgado P.

Drugs Today (Barc). 2004 Feb;40(2):121-31. Review.

PMID:
15045034
16.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
17.

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder.

Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS.

Ann Intern Med. 2005 Sep 20;143(6):415-26. Review.

PMID:
16172440
18.

Escitalopram (Lexapro) for depression.

Masilamani S, Ruppelt SC.

Am Fam Physician. 2003 Dec 1;68(11):2235-6. Review.

19.

Venlafaxine: a 2003 update.

Gutierrez MA, Stimmel GL, Aiso JY.

Clin Ther. 2003 Aug;25(8):2138-54. Review.

PMID:
14512125
20.

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

Smith D, Dempster C, Glanville J, Freemantle N, Anderson I.

Br J Psychiatry. 2002 May;180:396-404. Review.

Items per page

Supplemental Content

Write to the Help Desk